Exclusive

Publication

Byline

Location

US Patent Issued to Dr. Falk Pharma, Zedira on June 23 for "Systemic formulation of a pyridinone derivate for TG2-related diseases" (German Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,661,348, issued on June 23, was assigned to Dr. Falk Pharma GmbH (Freiburg, Germany) and Zedira GmbH (Darmstadt, Germany). "Systemic formulatio... Read More


US Patent Issued to LG CHEM on June 23 for "Pharmaceutically acceptable salt of sphingosine-1-phosphate receptor agonist, and crystalline form thereof" (South Korean Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,661,349, issued on June 23, was assigned to LG CHEM Ltd. (Seoul, South Korea). "Pharmaceutically acceptable salt of sphingosine-1-phosphate rec... Read More


US Patent Issued to Flex Pharma on June 23 for "Amorphous cabozantinib particles and uses thereof" (Minnesota Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,661,350, issued on June 23, was assigned to Flex Pharma LLC (New Brighton, Minn.). "Amorphous cabozantinib particles and uses thereof" was inve... Read More


US Patent Issued to INVENGENE on June 23 for "Stable liquid compositions of posaconazole" (Indian Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,661,351, issued on June 23, was assigned to INVENGENE PRIVATE Ltd. (Mumbai, India). "Stable liquid compositions of posaconazole" was invented b... Read More


US Patent Issued to Memorial Shan-Ketering Cancer Center, Memorial Hospital for Cancer and Allied Diseases, Sloan-Kettering Institute for Cancer Research, Biosplice Therapeutics on June 23 for "Combination therapy with CLK/DYRK inhibitors and BCL2 inhibitors to treat leukemia" (New York, California Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,661,352, issued on June 23, was assigned to Memorial Shan-Ketering Cancer Center (New York), Memorial Hospital for Cancer and Allied Diseases (N... Read More


US Patent Issued to Yeda Research and Development on June 23 for "SPT5 inhibitors and uses thereof" (Israeli Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,661,353, issued on June 23, was assigned to Yeda Research and Development Co. Ltd. (Rehovot, Israel). "SPT5 inhibitors and uses thereof" was in... Read More


US Patent Issued to BAHCESEHIR UNIVERSITESI, ISTANBUL TEKNIK UNIVERSITESI on June 23 for "DRG-MDM2-4 for use as a novel mouse double minute 2 (MDM2) inhibitor" (Turkish Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,661,354, issued on June 23, was assigned to BAHCESEHIR UNIVERSITESI (Istanbul) and ISTANBUL TEKNIK UNIVERSITESI (Istanbul). "DRG-MDM2-4 for use... Read More


US Patent Issued to The Regents of the University of California on June 23 for "Compounds and methods for inducing UCP1 expression" (California Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,661,355, issued on June 23, was assigned to The Regents of the University of California (Oakland, Calif.). "Compounds and methods for inducing ... Read More


US Patent Issued to TAIHO PHARMACEUTICAL on June 23 for "L718 and/or L792 mutant treatment-resistant EGFR inhibitor" (Japanese Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,661,356, issued on June 23, was assigned to TAIHO PHARMACEUTICAL Co. LTD. (Tokyo). "L718 and/or L792 mutant treatment-resistant EGFR inhibitor"... Read More


US Patent Issued to GUANGZHOU JOYO PHARMATECH, SHANGHAI JIA TAN PHARMATECH on June 23 for "Use of pyrido[1,2-apyrimidone analogue" (Chinese Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,661,357, issued on June 23, was assigned to GUANGZHOU JOYO PHARMATECH Co. LTD (Guangdong, China) and SHANGHAI JIA TAN PHARMATECH Co. LTD. (Shang... Read More